ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 123 filers reported holding ENANTA PHARMACEUTICALS INC in Q4 2014. The put-call ratio across all filers is 2.63 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2021 | $0 | – | 6 | 0.0% | 0.00% | – |
Q1 2021 | $0 | – | 6 | 0.0% | 0.00% | – |
Q4 2020 | $0 | – | 6 | 0.0% | 0.00% | – |
Q3 2020 | $0 | – | 6 | 0.0% | 0.00% | – |
Q2 2020 | $0 | -100.0% | 6 | -92.4% | 0.00% | – |
Q1 2020 | $4,000 | +33.3% | 79 | +41.1% | 0.00% | – |
Q3 2019 | $3,000 | -40.0% | 56 | 0.0% | 0.00% | – |
Q2 2019 | $5,000 | -50.0% | 56 | -44.0% | 0.00% | – |
Q1 2019 | $10,000 | -69.7% | 100 | -74.2% | 0.00% | – |
Q3 2018 | $33,000 | -84.1% | 387 | -78.5% | 0.00% | -100.0% |
Q2 2018 | $208,000 | +3366.7% | 1,798 | +1698.0% | 0.00% | – |
Q4 2017 | $6,000 | -82.9% | 100 | -87.1% | 0.00% | – |
Q2 2015 | $35,000 | +45.8% | 778 | 0.0% | 0.00% | – |
Q1 2015 | $24,000 | +300.0% | 778 | +380.2% | 0.00% | – |
Q3 2014 | $6,000 | +100.0% | 162 | +161.3% | 0.00% | – |
Q2 2014 | $3,000 | +200.0% | 62 | +181.8% | 0.00% | – |
Q1 2014 | $1,000 | – | 22 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Krensavage Asset Management, LLC | 862,848 | $42,556,000 | 14.73% |
Fairmount Funds Management LLC | 171,147 | $8,441,000 | 3.56% |
ARMISTICE CAPITAL, LLC | 1,648,000 | $81,279,000 | 1.87% |
FARALLON CAPITAL MANAGEMENT LLC | 1,995,000 | $98,393,000 | 0.49% |
Jackson Creek Investment Advisors LLC | 21,409 | $1,056,000 | 0.37% |
Hennion & Walsh Asset Management, Inc. | 113,940 | $5,620,000 | 0.34% |
Virtus ETF Advisers LLC | 14,721 | $726,000 | 0.31% |
Granahan Investment Management | 193,416 | $9,539,000 | 0.20% |
Yorktown Management & Research Co Inc | 4,500 | $222,000 | 0.18% |
JACOBS LEVY EQUITY MANAGEMENT, INC | 242,257 | $11,948,000 | 0.09% |